Arqit Quantum (ARQQ) Stock Looks Expensive Even After Its $7 Million Legal Settlement
ARQIT QUANTUM INC ARQQ | 0.00 |
Arqit Quantum (NasdaqCM:ARQQ) has agreed to a US$7 million settlement resolving all U.S. securities class actions, closing multi year disputes over alleged misstatements about its quantum encryption technology and revenue sources.
The recent 7 day share price return of 79.3%, including a 7.9% move in the last session to US$24.38, suggests momentum has picked up quickly, even though the 1 year total shareholder return is still down 41.5% and the 5 year total shareholder return is down 90.2%. This points to a long term record that remains weak despite the lift following Arqit Quantum’s settlement news.
If this legal resolution has you rethinking opportunities in quantum security and related themes, it could be a good moment to scan the market using our screener of 31 quantum computing stocks
With Arqit Quantum now past a long running legal overhang and trading well below the current US$60 analyst price target, the real question is whether the stock is still mispriced, or if the market now fully reflects its future potential.
Price to Book: Is Arqit Quantum’s 14.2x Multiple Justified?
At a P/B ratio of 14.2x, Arqit Quantum is priced far above both its direct peers at 2x and the broader US Software industry at 2.8x. This points to a valuation that is hard to call conservative at the last close of $24.38.
The price to book ratio compares the company’s market value to its net assets on the balance sheet. A higher multiple often implies investors are willing to pay a premium for factors such as potential future growth, margins or intangible assets that are not captured in book value. For Arqit Quantum, that premium sits against a backdrop of reported revenue of about $1.1m and a current net loss of $49.0m, so investors are effectively paying a high price relative to the existing asset and income base.
Compared with both peer averages and the wider US Software group, Arqit Quantum’s 14.2x P/B ratio is several times higher. At the same time, the company is unprofitable, carries less than one year of cash runway and has a history of shareholder dilution and recent insider selling. In this context, the current multiple appears significantly higher than the peer and industry benchmarks.
Result: Price-to-book of 14.2x (OVERVALUED)
However, Arqit Quantum still carries risks, including its current net loss of US$49.0m and less than one year of cash runway, which could put pressure on future funding needs.
Next Steps
With mixed signals around Arqit Quantum’s valuation and financial footing, it may be useful to act promptly, review the full picture and form your own judgment using the 1 key reward and 6 important warning signs.
Looking For More Investment Ideas Beyond Arqit Quantum?
If Arqit Quantum has sharpened your interest in fresh opportunities, do not stop here. Broaden your watchlist with other focused ideas that match your investing style.
- Target potential upside by scanning a curated set of screener containing 19 high quality undiscovered gems that combine quality fundamentals with lower market attention.
- Prioritize resilience and sleep better at night by reviewing 65 resilient stocks with low risk scores that score well on stability and downside protection.
- Strengthen your core holdings with companies filtered through the solid balance sheet and fundamentals stocks screener (48 results) so you focus on businesses backed by robust financial footing.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
